Subcutaneous Abatacept in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis: Results From a Phase III Open‐Label Study

OBJECTIVE: To investigate the pharmacokinetics, effectiveness, and safety of subcutaneous (SC) abatacept treatment over 24 months in patients with polyarticular‐course juvenile idiopathic arthritis (JIA). METHODS: In this phase III, open‐label, international, multicenter, single‐arm study, patients...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Arthritis Rheumatol
Hlavní autoři: Brunner, Hermine I., Tzaribachev, Nikolay, Vega‐Cornejo, Gabriel, Louw, Ingrid, Berman, Alberto, Calvo Penadés, Inmaculada, Antón, Jordi, Ávila‐Zapata, Francisco, Cuttica, Rubén, Horneff, Gerd, Foeldvari, Ivan, Keltsev, Vladimir, Kingsbury, Daniel J., Viola, Diego Oscar, Joos, Rik, Lauwerys, Bernard, Paz Gastañaga, Maria Eliana, Rama, Maria Elena, Wouters, Carine, Bohnsack, John, Breedt, Johannes, Fischbach, Michel, Lutz, Thomas, Minden, Kirsten, Miraval, Tatiana, Ally, Mahmood M. T. M., Rubio‐Pérez, Nadina, Solau Gervais, Elisabeth, van Zyl, Riana, Li, Xiaohui, Nys, Marleen, Wong, Robert, Banerjee, Subhashis, Lovell, Daniel J., Martini, Alberto, Ruperto, Nicolino
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
Pediatric Rheumatology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6032847/
https://ncbi.nlm.nih.gov/pubmed/29481737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40466
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky